OTCMKTS:AUGX Augmedix (AUGX) Stock Price, News & Analysis $2.35 0.00 (0.00%) As of 10/2/2024 Add Compare Share Share Stock Analysis Stock Analysis About Augmedix Stock (OTCMKTS:AUGX) Get Augmedix alerts:Sign Up Key Stats Today's Range$2.35▼$2.3550-Day Range$2.35▼$2.3552-Week Range$0.73▼$6.25VolumeN/AAverage Volume635,746 shsMarket Capitalization$115.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Augmedix, Inc. was a healthcare technology company that developed solutions to reduce the administrative burden associated with clinical documentation. Its platform used artificial intelligence, natural language processing and, in some offerings, trained medical documentation specialists to convert patient-clinician conversations into structured medical notes. The company’s products were designed to support physicians and other healthcare professionals during and after patient visits. Its offerings included ambient documentation tools that captured and summarized clinical conversations, as well as services that combined automation with human review. These solutions were intended to integrate with electronic health record systems and help healthcare organizations improve workflow efficiency and give clinicians more time to focus on patient care. Founded in 2012, Augmedix primarily served healthcare providers and enterprise customers in the United States, with its technology used across multiple medical specialties and care settings. Augmedix became a publicly traded company in 2021. In 2024, the company was acquired by Commure, a healthcare technology platform, and Augmedix subsequently ceased operating as an independent public company.AI Generated. May Contain Errors. Read More Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AUGX Stock News HeadlinesAugmedix Delivers 27% Revenue Growth for Second Quarter of 2024June 10, 2026 | stockhouse.comLake Street Downgrades Augmedix (AUGX)July 23, 2024 | msn.comThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets. | Behind the Markets (Ad)SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Augmedix, Inc. BuyoutJuly 22, 2024 | stockhouse.comAugmedix Agrees to $139 Million Acquisition by CommureJuly 19, 2024 | marketwatch.comAUGX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Augmedix, Inc. Is Fair to ShareholdersJuly 19, 2024 | tmcnet.comAI-Focused Healthcare Documentation Provider Augmedix Goes Private In $139M DealJuly 19, 2024 | msn.comAugmedix to be acquired by Commure in transaction valuing the former at ~$139MJuly 19, 2024 | msn.comSee More Headlines AUGX Stock Analysis - Frequently Asked Questions How have AUGX shares performed this year? Augmedix's stock was trading at $2.35 at the beginning of the year. Since then, AUGX stock has increased by 0.0% and is now trading at $2.35. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) announced its earnings results on Monday, March, 27th. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.16) by $0.01. The business had revenue of $8.75 million for the quarter, compared to analysts' expectations of $8.52 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%. Company Calendar Last Earnings3/27/2023Today10/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolOTCMKTS:AUGX CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees710Year Founded2012Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$24.45 million Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$51.58 million Price / Sales2.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book23.50Miscellaneous Outstanding Shares48,968,000Free Float36,316,000Market Cap$115.07 million OptionableNot Optionable Beta-0.22 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:AUGX) was last updated on 10/2/2024 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
